In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
no speaker photo
Speaker
Joao AGOSTINHO
Joao AGOSTINHO Joao AGOSTINHO

Hospital Universita­rio de Santa Maria/CHULN CAML CCUL Lisbon School of Medicine of the Universidade, Lisbon (Portugal)

Specialities : Chronic Heart Failure , Acute Heart Failure, Chronic Heart Failure, Acute Cardiac Care, Public Health and Health Economics

20 presentations from this speaker

ARNI use in clinical practice: PARADIGM-HF trial results applied to the real world

Event : Heart Failure 2019

  • Session : Chronic Heart Failure – Treatment
  • Speaker : J AGOSTINHO (Lisboa,PT)

Clinical impact of non-invasive telemonitoring in patients with chronic heart failure

Event : Heart Failure 2019

  • Session : e-Cardiology / Digital Health
  • Speaker : J AGOSTINHO (Lisboa,PT)

Comparative analysis of multiparametric scores in heart failure: does the type of follow-up matter?

Event : Heart Failure 2019

  • Session : Chronic Heart Failure – Epidemiology, Prognosis, Outcome
  • Speaker : J AGOSTINHO (Lisboa,PT)

MitraClip: impact on symptoms and quality of life

Event : Heart Failure 2019

  • Session : Valvular Heart Disease
  • Speaker : J AGOSTINHO (Lisboa,PT)

Neurohormonal antagonist therapies, renal function and kalaemia: a trade-off to consider when treating heart failure patients

Event : Heart Failure 2019

  • Session : Chronic Heart Failure – Pathophysiology and Mechanisms
  • Speaker : J AGOSTINHO (Lisboa,PT)

Prescription of sacubitril/valsartan in a real-world population

Event : Heart Failure 2019

  • Session : Chronic Heart Failure – Treatment
  • Speaker : J AGOSTINHO (Lisboa,PT)

Predicting readmissions in patients with heart failure: a novel and easy-to-apply scoring model

Event : Heart Failure 2018

  • Session : Chronic Heart Failure – Epidemiology, Prognosis, Outcome
  • Speaker : J AGOSTINHO (Lisboa,PT)

Preliminary study of RESYS: computer alert system for device implantation

Event : ESC Congress 2018

  • Session : Subcutaneous ICD
  • Speaker : J AGOSTINHO (Lisboa,PT)

Sexual dysfunction in patients with heart failure: a therapeutic limitation for the patient or the physician?

Event : Heart Failure 2018

  • Session : Chronic Heart Failure - Clinical
  • Speaker : J AGOSTINHO (Lisboa,PT)

Structured follow-up program of patients with heart failure: impact on quality of life and prognosis.

Event : Heart Failure 2018

  • Session : Patient management - From oral treatment to transplant
  • Speaker : J AGOSTINHO (Lisboa,PT)

Echocardiographic mortality predictors in patients with severe aortic stenosis not submited to valvular intervention

Event : Heart Failure 2017

  • Session : Valvular heart disease (diagnosis, management and interventional therapies)
  • Speaker : J AGOSTINHO (Lisboa,PT)

Predictors of prolonged hospitalization in acute heart failure

Event : Heart Failure 2017

  • Session : Acute heart failure
  • Speaker : J AGOSTINHO (Lisboa,PT)

Prognostic value of NT-proBNP, adrenomedullin, copeptin and proenkephalin in patients with pulmonary hypertension

Event : ESC Congress 2017

  • Session : Pulmonary hypertension : course and prognosis
  • Speaker : J AGOSTINHO (Lisboa,PT)

Severe aortic stenosis: experience and outcomes of a tertiary center

Event : Heart Failure 2017

  • Session : Valvular heart disease (diagnosis, management and interventional therapies)
  • Speaker : J AGOSTINHO (Lisboa,PT)

Timely surgical intervention in patients with infective endocarditis: still a key to survival

Event : Acute Cardiovascular Care 2016

  • Session : Cardiac surgery
  • Speaker : J AGOSTINHO (Lisboa,PT)

Get your access to resources

Join now
  • 1ESC Professional Members – access all ESC Congress resources 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are